Current Osteoporosis Reports

, Volume 10, Issue 1, pp 48–55

Osteoporosis After Transplantation

  • Carolina A. Moreira Kulak
  • Victoria Z. Cochenski Borba
  • Jaime Kulak Júnior
  • Melani Ribeiro Custódio
Current Therapeutics (SL Silverman, Section Editor)

DOI: 10.1007/s11914-011-0083-y

Cite this article as:
Kulak, C.A.M., Borba, V.Z.C., Júnior, J.K. et al. Curr Osteoporos Rep (2012) 10: 48. doi:10.1007/s11914-011-0083-y

Abstract

Transplantation is an established therapy for end-stage diseases of kidney, lung, liver, and heart among others. Osteoporosis and fragility fractures are serious complications of organ transplantation, particularly in the first post-transplant year. Many factors contribute to the pathogenesis of osteoporosis following organ transplantation. This review addresses the mechanisms of bone loss that occurs both in the early and late post-transplant periods, including the contribution of the immunosuppressive agents as well as the specific features to bone loss after kidney, lung, liver, cardiac, and bone marrow transplantation. Prevention and treatment for osteoporosis in the transplant recipient are also discussed.

Keywords

Secondary osteoporosisTransplantationImmunosuppressive agentsBone loss

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Carolina A. Moreira Kulak
    • 1
    • 3
  • Victoria Z. Cochenski Borba
    • 2
    • 3
  • Jaime Kulak Júnior
    • 4
  • Melani Ribeiro Custódio
    • 5
  1. 1.Division of Endocrinology & Metabolism of Hospital de Clínicas - SEMPRFederal University of ParanaCuritibaBrazil
  2. 2.Endocrinology Division of Hospital de ClinicasFederal University of Parana Serviço de Endocrinologia e Metabologia HC-UFPR (SEMPR)Q1 CuritibaBrazil
  3. 3.Department of Internal MedicineFederal University of ParanaCuritibaBrazil
  4. 4.Department of Obstetrics & GynecologyFederal University of ParanaCuritibaBrazil
  5. 5.Department of Internal MedicineNephrology Division, Universidade de São PauloSão PauloBrazil